Senti Biosciences Future Growth
How is Senti Biosciences forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
Future Growth Score
0/6Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
-26.0%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 5 | N/A | -120 | N/A | 1 |
| 12/31/2024 | 7 | -94 | -101 | -92 | 2 |
| 12/31/2023 | 6 | -86 | -89 | -81 | 3 |
| 9/30/2022 | 5 | -51 | -75 | -38 | N/A |
| 6/30/2022 | 4 | -46 | -60 | -37 | N/A |
| 3/31/2022 | 4 | -46 | -49 | -36 | N/A |
| 12/31/2021 | 3 | -55 | -40 | -35 | N/A |
| 9/30/2021 | 2 | -45 | -32 | -30 | N/A |
| 12/31/2020 | 1 | -20 | -25 | -24 | N/A |
| 12/31/2019 | 0 | -21 | -20 | -18 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SNTI is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: SNTI is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: SNTI is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: SNTI's revenue is expected to decline over the next 3 years (-10% per year).
High Growth Revenue: SNTI's revenue is forecast to decline over the next 3 years (-10% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SNTI is forecast to be unprofitable in 3 years.